about
Molecular Mechanism of Adult Neurogenesis and its Association with Human Brain DiseasesHerpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's DiseaseTreatment of beta amyloid 1-42 (Aβ(1-42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivoAlzheimer's disease: Targeting the Cholinergic SystemSystematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble saltsMagnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Effects of vitamins E and C combined with β-carotene on cognitive function in the elderly.A loss of function variant in CASP7 protects against Alzheimer's disease in homozygous APOE ε4 allele carriers.Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer's disease modelsAlzheimer's disease: are blood and brain markers related? A systematic review.Alzheimer's disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratioThe Role of TDP-43 in Alzheimer's Disease.Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain FunctionProteomics as an innovative tool to investigate frontotemporal disorders.Phytosterols and Dementia.Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites.Mediation of insulin growth factor-1 in Alzheimer's disease and the mechanism of PRNP genetic expression and the PI3K/Akt signaling pathway.Inhibitory effect of corcin on aggregation of 1N/4R human tau protein in vitro.Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer's Disease.Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.Spinal cord injury and Alzheimer's disease risk: a population-based, retrospective cohort study.[Dementia and otorhinolaryngologic practice].Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.Antibodies to Glutamate Reversed the Amnesic Effects of Proinflammatory S100A9 Protein Fibrils in Aged C57Bl/6 Mice.Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits.Effect of flavonoids rich extract of Capparis spinosa on inflammatory involved genes in amyloid-beta peptide injected rat model of Alzheimer's disease.Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases.Effects of acidic oligosaccharide sugar chain on amyloid oligomer-induced impairment of synaptic plasticity in rats.Lanthionine ketimine-5-ethyl ester provides neuroprotection in a zebrafish model of okadaic acid-induced Alzheimer's disease.Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.Modeling Alzheimer's and Other Age Related Human Diseases in Embryonic Systems.Curcumin Treatment is Associated with Increased Expression of the N-Methyl-D-Aspartate Receptor (NMDAR) Subunit, NR2A, in a Rat PC12 Cell Line Model of Alzheimer's Disease Treated with the Acetyl Amyloid-β Peptide, Aβ(25-35).Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognitionIs Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease?Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review
P2860
Cdk5 activity in the brain - multiple paths of regulation.The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.Neuropharmacologic Approaches to Restore the Brain's Microenvironment.Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies.Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.Human Umbilical Cord Blood Serum-derived α-Secretase: Functional Testing in Alzheimer's Disease Mouse Models.β-Amyloid accumulation in the human brain after one night of sleep deprivation.Different Expression Levels of Human Mutant Ubiquitin B+1 (UBB+1) Can Modify Chronological Lifespan or Stress Resistance of Saccharomyces cerevisiae.Evaluation of Acute and Chronic Effects of D-Galactose on Memory and Learning in Wistar Rats.L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer's DiseaseBACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s DiseaseAltered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer's DiseaseMedical Plants and Nutraceuticals for Amyloid-β Fibrillation InhibitionSynthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agentsWhite matter capillaries in vascular and neurodegenerative dementiasDecreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-AnalysisWhat is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and DiseasesMaintenance of occupational therapy (OT) for dementia: protocol of a multi-center, randomized controlled and pragmatic trialImportant advances in Alzheimer's disease from the use of induced pluripotent stem cells4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysisTargeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer's DiseaseNrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological DisordersIs Dementia More Fatal Than Previously Estimated? A Population-based Prospective Cohort StudyTrkB-ICD Fragment, Originating From BDNF Receptor Cleavage, Is Translocated to Cell Nucleus and Phosphorylates Nuclear and Axonal ProteinsHydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's diseaseThe APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer's diseaseInferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's diseaseContext-sensitive network analysis identifies food metabolites associated with Alzheimer's disease: an exploratory studyIdentification of exon skipping events associated with Alzheimer's disease in the human hippocampusManual Acupuncture Regulates Behavior and Cerebral Blood Flow in the SAMP8 Mouse Model of Alzheimer's DiseaseAssessing the role of in periodontitis to determine a causative relationship with Alzheimer's diseaseRescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein AntagonistsEffects of δ-Catenin on APP by Its Interaction with Presenilin-1Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's diseaseComparative Analysis of Antioxidant and Anti-Amyloidogenic Properties of Various Polyphenol Rich Phytoceutical ExtractsGeniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's diseaseGlucocorticoid Induced Leucine Zipper in Lipopolysaccharide Induced Neuroinflammation
P921
Q26745434-2D68B164-01E9-4AA1-A408-23BFC016122FQ26781578-1727F94D-AF9F-479F-84A1-3A2D00C8152AQ27349070-AEECCA34-6718-40E2-8F3A-E9B807429A83Q28070135-87A3ED38-EB7C-468D-84E3-674C882677B8Q28387541-DE14F46F-BA93-46ED-8864-12C86177E846Q30996805-0586776E-32FC-452E-8D3F-75719FE28A80Q35159740-84E741BF-9AF3-486A-AF04-D350690848AEQ36064459-7F89D25F-32DA-4D0F-A082-769A18D580B2Q36787765-123B8378-909A-49A7-8755-EF4233D7358CQ36966044-8134DBE8-9D3F-4720-A8EB-873E3F4147F3Q37195665-D19B6E4D-E416-4C5A-BF4A-AEBB3E0058C2Q38529627-1398E13B-DA28-474E-99BC-EE9C7A5ED2DFQ38536860-7D18A062-9F80-4710-8B5A-CFD3C02BC0D6Q38802995-2803DE8F-32BB-48BC-B763-7D36DE3E453BQ38963194-AE9C062E-FBD9-4900-AF2C-53FC12923C82Q39022532-6885B184-4E19-4E17-839D-B6DAC31E6204Q41685392-33ADF4EF-DACD-4498-BD96-C36C2BEE06D4Q41780314-4C052B71-24BD-4F0B-B15C-45ABC2D0570DQ42414528-3EADD174-B46C-4352-85C6-5B093F8968D1Q47113314-FA0BFA6D-7D70-4EFE-9481-3D971E04E9ACQ47256814-74D96F6B-A337-4DC1-8A0E-BC224D2BC568Q47683018-82FEBFDA-10E1-426B-AE9B-90E0C4D879C2Q47687700-1601318B-E128-4063-A7FD-9F692A0BB266Q47979606-F042AC72-FD99-42F8-B489-17ACEBE63BC8Q50067066-24A6DC2E-4A0A-4B0B-9ED3-6C2E2EC8F9F1Q50354620-138CBF0A-9B16-4E38-AFD9-D6EF61B9F43EQ50436669-3600E2B1-3249-4FFA-83B2-CEA38CE56FDEQ50453861-310DC2B5-733B-4A82-8E61-6D372AA8E424Q50849731-8CD5438D-F332-40CE-9768-2B9BE05A5F09Q51124693-5DE2C8BD-94F3-4F61-8A55-836441342C72Q51761118-FCCBB002-816F-46DA-B6DC-B9F43A45B632Q51764192-CB248237-717E-4B8F-B96D-B627E1C1FB7FQ52649290-E6FE6BB7-932A-49C4-9976-724495ECBA12Q52730744-5CD648D8-1488-4D47-9606-7777D89F6968Q53137779-82312C29-E890-4E3E-AA61-E2B8B831B9CDQ54952915-37086317-3EFC-4777-AB1C-62547A4FD34CQ54968424-C3316F2B-C593-48E1-818B-C5FFA1FE1950Q57143976-C5ABE95A-1BC8-47D7-ACD7-3C8B5764065FQ57211696-40281CD8-2ED1-4930-976E-8E3CE59B679EQ58549216-41D4AD28-68C5-49A7-A55A-7CFCBFB8C1F5
P2860
Q33687591-424ECB53-1273-4880-A8FB-0587B7D9C7F7Q36803492-21DF30C4-7174-4EFA-B078-807303D0C431Q37053816-1B7064FD-8C6E-4CF9-8B61-7D41A7EDD680Q38879533-D13C9CAB-6014-48F2-9957-FB04B6068F6EQ39016551-02B166F7-7447-48F6-80BF-6386DE626009Q39021109-A2947548-4F6D-42CF-BC0F-C94BAD475B1BQ41463305-EACE1686-8381-4658-831F-331FAC2145B6Q51730352-60143EF1-D173-4542-8DBF-41EFF8B4574CQ52597873-1612EF9F-735D-48D1-82E7-10718EB26C81Q55315713-2C9BAC1B-7E8F-4684-99E0-C2E5048C9D0FQ55399891-C2321D0B-E634-4A25-8813-1141E6BAF041Q57030260-B7E41FB9-B986-477C-8E83-5033D799B843Q60595359-A4CEAA46-C18A-47C1-BF34-0B858955A8A6Q60916157-70377CD4-5E79-4051-A361-EB3BA8097C4EQ60933008-6E4F11B8-7890-431C-911E-D03075DB6825Q60934970-8C054264-95BB-41EC-A46E-EE34BB511616Q61796600-E2568C18-AEAD-4A43-9EEF-23669FB928ECQ61797709-8DCE3BE3-0A03-4A8E-A7F7-C07C70FE994CQ61797874-B67AA9E0-DA29-4B60-8DEC-807588E62CF8Q61798123-540811F1-67E2-4659-BA41-091B847816D7Q61798426-0054A7A5-21C9-48CE-B786-9AC18E27CE3FQ61798848-E9E796A9-ED9C-41C0-B625-676580E1AF44Q61798857-619DC535-6DA8-4EED-890F-E9BDC6C082E1Q61800077-2F1FC159-DA71-4D3B-AA37-16374AE97186Q61800105-5E441DE0-6497-4DAA-8BAD-F2F248D6123EQ61801338-F990039E-C349-4350-AE57-CF92DDF889C9Q61803793-7726116C-C92E-4321-B695-09F9CDFAD9DAQ61804653-99CEEE43-E823-4697-A3C2-F2AB258A49A0Q61804675-1EA42434-1A66-4032-A020-F56D8AB3FB51Q61804684-1A872950-6A10-46C3-B055-366790DA34E8Q61804776-B4DBFEB8-21F0-46DA-BA3F-A09CB8F10B60Q61804796-513E33ED-0542-4EC9-9F70-202AFA9FDE61Q61805145-E5C4C293-64FD-4BB1-B849-7E0902C6B788Q61807350-D7E9817E-FDFB-4E89-A973-947D314BD5E3Q61807500-FC215B17-EE84-4ED2-8516-05B9B9E42C4DQ61807744-56F38EDF-273E-4A32-9C45-CF018EADBABEQ61808266-77C03DA9-016D-4BAF-B20E-DE73851C3B2BQ61808388-94A8CAC7-37B3-4E79-BF27-AF8258FCB0A4Q61808748-7D2E2484-6740-4557-9A73-D1A791210A5BQ61809053-45E8A44C-A0ED-4B90-A376-D204C1D28C77
P921
description
article from 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2012
@uk
name
Alzheimer’s Disease
@en
Alzheimer’s Disease
@nl
type
label
Alzheimer’s Disease
@en
Alzheimer’s Disease
@nl
prefLabel
Alzheimer’s Disease
@en
Alzheimer’s Disease
@nl
P2093
P1476
Alzheimer's disease
@en
P2093
Marcia Radanovic
Orestes V Forlenza
Vanessa J De-Paula
P304
P356
10.1007/978-94-007-5416-4_14
P577
2012-01-01T00:00:00Z